Evidence map›Paper›PMID 29771390›Full record

Trial reportNicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco2019

Children Learning About Secondhand Smoke (CLASS II): A Pilot Cluster Randomized Controlled Trial.

Kamran Siddiqi, Rumana Huque, Mona Kanaan, Farid Ahmed, Tarana Ferdous, Sarwat Shah, Cath Jackson, Steve Parrott, Jasjit S Ahluwalia, Aziz Sheikh

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The silent assassin: Third hand smoking.Journal of global health · 2022
    Article
  5. Article
  6. Smoke-free homes: The final frontier.Tobacco prevention & cessation · 2021
    Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Kamran SiddiqiDepartment of Health Sciences, University of York Seebohm Rowntree Building, Heslighton, York, UK.
Rumana HuqueDepartment of Economics, University of Dhaka Social Science Building, Dhaka, Bangladesh.
Mona KanaanDepartment of Health Sciences, University of York Seebohm Rowntree Building, Heslighton, York, UK.
Farid AhmedARK Foundation, Dhaka, Bangladesh.
Tarana FerdousARK Foundation, Dhaka, Bangladesh.
Sarwat ShahDepartment of Health Sciences, University of York ARRC Building, University of York, Heslington, York, UK.
Cath JacksonDepartment of Health Sciences, University of York ARRC Building, University of York, Heslington, York, UK.
Steve ParrottDepartment of Health Sciences, University of York ARRC Building, University of York, Heslington, York, UK.
Jasjit S AhluwaliaBrown University School of Public Health, Providence, RI.
Aziz SheikhUsher Institute of Population Health Sciences and Informatics, The University of Edinburgh Teviot Place, Edinburgh, UK.
University of York · GBARK Foundation · BDBrown University · USUniversity of Dhaka · BDUniversity of Edinburgh · GB

Funding

Medical Research Council MR/K023195/1Medical Research Council MR/M020533/1
6 · The paper itself

Abstract

introductionChildren exposed to secondhand smoke (SHS) are at increased risk of respiratory illnesses. We piloted a Smoke Free Intervention (SFI) and trial methods before investigating its effectiveness and cost-effectiveness in primary school children.

methodsIn a pilot cluster randomized controlled trial in Bangladesh, primary schools were allocated to usual education (control) or SFI, using minimization. Year-5 children were recruited. Masking treatment allocation was not possible. Delivered by schoolteachers, SFI consisted of two 45-min and four 15-min educational sessions. Our primary outcome was SHS exposure at two months post randomization, verified by children's salivary cotinine. The trial is registered at ISRCTN.com; ISRCTN68690577.

resultsBetween April 1, 2015 and June 30, 2015, we recruited 12 schools. Of the 484 children present in Year-5, 481 consented. Six schools were allocated to both SFI (n = 245) and to usual education only (n = 236). Of them, 450 children (SFI = 229; control = 221) who had cotinine levels indicative of SHS exposure were followed-up. All schools were retained, 91% children (208/229) in SFI and 88% (194/221) in the control arm completed primary outcome assessment. Their mean cotinine at the cluster level was 0.53 ng/ml (SD 0.36) in SFI and 1.84 ng/ml (SD 1.49) in the control arm-a mean difference of -1.31 ng/ml (95% CI = -2.86 to 0.24).

conclusionIt was feasible to recruit, randomize, and retain primary schools and children in our trial. Our study, though not powered to detect differences in mean cotinine between the two arms, provides estimates to inform the likely effect size for future trials. IMPLICATIONS: In countries with high smoking prevalence, children remain at risk of many conditions due to secondhand smoke exposure. There is little empirical evidence on the effectiveness and cost-effectiveness of interventions that can reduce their exposure to secondhand smoke at homes. CLASS II trial found that a school-based intervention (SFI) has the potential to reduce children's exposure to SHS-an approach that has been rarely used, but has considerable merit in school-based contexts. CLASS II trial provides key information to conduct a future definitive trial in this area of public health, which despite its importance has so far received little attention.

Indexed as

LearningSchoolsBangladeshChildCluster AnalysisCost-Benefit AnalysisCotinineFemaleFollow-Up StudiesHumansMaleOutcome Assessment, Health CarePilot ProjectsSalivaStudentsTobacco Smoke PollutionCotinineTobacco Smoke Pollution

Identifiers

PMID29771390
PMCPMC6468126
OpenAlexW2804029092

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.